Reaffirming its commitment in Making India health confident, Apollo Munich Health insurance has introduced a comprehensive cancer plan, aptly-named iCan. It is a lifelong coverage plan and comes with an annual renewal policy year after year, even after claim. The plan not only covers the basic medical needs, but also provide complete financial security to the patient as well as the family at all stages of cancer.

This distinctive and innovative cancer plan covers all forms of cancer, at both early and advanced stages. Apart from the standard plan that covers conventional treatment like Chemotherapy, Radiotherapy and organ transplant, this policy also gives an optional benefit of getting advance treatments like Proton beam therapy, Hormonal therapy, Stem cell transplantation, Immunotherapy.

The plan comes with features such as CritiCare and FamilyCare wherein the policy holder gets 60% of sum insured as the lumpsum payment on diagnosis of cancer and 100% on diagnosis of advanced stages or recurrence of cancer, which is in addition to the hospitalization cost. It also offers lifelong renewal that covers the policyholder regardless of the health status or claims of policy holder.

Speaking on this announcement, Mr. Antony Jacob, Chief Executive Officer, Apollo Munich Health Insurance said, “With the changing lifestyle, we have been witnessing an increase in number of people getting diagnosed with cancer. Every year over 7 lakh Indians are registered as cancer patients and today the estimated number of Indians living with cancer is around 2.5 million. It is perhaps for figures such as these that thought-through cancer policies are the need of the hour.”

“We have conceptualized this plan keeping in mind three aspects – i) The economic burden of cancer negatively impacting families' ability to manage their cost of living with high treatment costs pushing them further into poverty, ii) The cost of advance treatments, if the person reaches advanced stage, iii) cancer treatment is often long and expensive. With the launch of iCan, we have introduced customer centric features like support for family, pre and post hospitalization including lifelong renewal among several others. It is a “future ready” product which covers advanced treatments while also offering second opinion by using sophisticated cognitive systems like using IBM Watson for Oncology to enable people make more informed treatment decisions. We look forward to serve our customers with improved products and we are confident that iCan will bring positive change in the communities at large through this distinctive offering,” he added.